The influence of finasteride on the development of prostate cancer
- Author
- THOMPSON, Ian M1 ; GOODMAN, Phyllis J2 ; CARLIN, Susie M2 ; RYAN, Anne4 ; SZCZEPANEK, Connie M9 ; CROWLEY, John J2 ; COLTMAN, Charles A10 ; TANGEN, Catherine M2 ; LUCIA, M. Scott3 ; MILLER, Gary J3 ; FORD, Leslie G4 ; LIEBER, Michael M5 ; CESPEDES, R. Duane6 ; ATKINS, James N7 ; LIPPMAN, Scott M8
[1] University of Texas Health Science Center, San Antonio, United States
[2] Southwest Oncology Group Statistical Center, Seattle, United States
[3] University of Colorado, Denver, United States
[4] National Cancer Institute, Bethesda, Md, United States
[5] Mayo Clinic, Rochester, Minn., United States
[6] Wilford Hall U.S. Air Force Medical Center, San Antonio, Tex., United States
[7] Southeastern Medical Oncology Center, Goldsboro, N.C., United States
[8] M.D. Anderson Cancer Center, Houston, United States
[9] Grand Rapids Community Clinical Oncology Program, Grand Rapids, Mich., United States
[10] Southwest Oncology Group Operations Office, San Antonio, Tex., United States - Source
The New England journal of medicine. 2003, Vol 349, Num 3, pp 215-224, 10 p ; ref : 28 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Boston, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Analyse statistique Azastéroïde Chimioprophylaxie Effet secondaire Efficacité traitement Finastéride Homme Individu sain Long terme Mâle Prostate Randomisation Toxicité Tumeur maligne Antiandrogène Anticancéreux Antihormone Appareil génital mâle pathologie Appareil urinaire pathologie Prostate pathologie
- Keyword (en)
- Statistical analysis Azasteroid Chemoprophylaxis Secondary effect Treatment efficiency Finasteride Human Healthy subject Long term Male Prostate Randomization Toxicity Malignant tumor Antiandrogen Antineoplastic agent Antihormone Male genital diseases Urinary system disease Prostate disease
- Keyword (es)
- Análisis estadístico Azasteroide Quimioprofilaxis Efecto secundario Eficacia tratamiento Finasterida Hombre Individuo sano Largo plazo Macho Prostata Aleatorización Toxicidad Tumor maligno Antiandrógeno Anticanceroso Antihormona Aparato genital macho patología Aparato urinario patología Prostata patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 14952641
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa030660 
https://dx.doi.org/10.1056/NEJMoa030660
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:3:\"349\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"215\";s:8:\"\u0000*\u0000epage\";s:3:\"224\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"THOMPSON\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"GOODMAN, Phyllis J\";i:1;s:15:\"CARLIN, Susie M\";i:2;s:10:\"RYAN, Anne\";i:3;s:20:\"SZCZEPANEK, Connie M\";i:4;s:15:\"CROWLEY, John J\";i:5;s:18:\"COLTMAN, Charles A\";i:6;s:19:\"TANGEN, Catherine M\";i:7;s:15:\"LUCIA, M. Scott\";i:8;s:14:\"MILLER, Gary J\";i:9;s:14:\"FORD, Leslie G\";i:10;s:17:\"LIEBER, Michael M\";i:11;s:18:\"CESPEDES, R. Duane\";i:12;s:15:\"ATKINS, James N\";i:13;s:16:\"LIPPMAN, Scott M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:3:\"349\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"215\";s:8:\"\u0000*\u0000epage\";s:3:\"224\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"THOMPSON\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"GOODMAN, Phyllis J\";i:1;s:15:\"CARLIN, Susie M\";i:2;s:10:\"RYAN, Anne\";i:3;s:20:\"SZCZEPANEK, Connie M\";i:4;s:15:\"CROWLEY, John J\";i:5;s:18:\"COLTMAN, Charles A\";i:6;s:19:\"TANGEN, Catherine M\";i:7;s:15:\"LUCIA, M. Scott\";i:8;s:14:\"MILLER, Gary J\";i:9;s:14:\"FORD, Leslie G\";i:10;s:17:\"LIEBER, Michael M\";i:11;s:18:\"CESPEDES, R. Duane\";i:12;s:15:\"ATKINS, James N\";i:13;s:16:\"LIPPMAN, Scott M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:3:\"349\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"215\";s:8:\"\u0000*\u0000epage\";s:3:\"224\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"THOMPSON\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"GOODMAN, Phyllis J\";i:1;s:15:\"CARLIN, Susie M\";i:2;s:10:\"RYAN, Anne\";i:3;s:20:\"SZCZEPANEK, Connie M\";i:4;s:15:\"CROWLEY, John J\";i:5;s:18:\"COLTMAN, Charles A\";i:6;s:19:\"TANGEN, Catherine M\";i:7;s:15:\"LUCIA, M. Scott\";i:8;s:14:\"MILLER, Gary J\";i:9;s:14:\"FORD, Leslie G\";i:10;s:17:\"LIEBER, Michael M\";i:11;s:18:\"CESPEDES, R. Duane\";i:12;s:15:\"ATKINS, James N\";i:13;s:16:\"LIPPMAN, Scott M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:3:\"349\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"215\";s:8:\"\u0000*\u0000epage\";s:3:\"224\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"THOMPSON\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"GOODMAN, Phyllis J\";i:1;s:15:\"CARLIN, Susie M\";i:2;s:10:\"RYAN, Anne\";i:3;s:20:\"SZCZEPANEK, Connie M\";i:4;s:15:\"CROWLEY, John J\";i:5;s:18:\"COLTMAN, Charles A\";i:6;s:19:\"TANGEN, Catherine M\";i:7;s:15:\"LUCIA, M. Scott\";i:8;s:14:\"MILLER, Gary J\";i:9;s:14:\"FORD, Leslie G\";i:10;s:17:\"LIEBER, Michael M\";i:11;s:18:\"CESPEDES, R. Duane\";i:12;s:15:\"ATKINS, James N\";i:13;s:16:\"LIPPMAN, Scott M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa030660\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:3:\"349\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"215\";s:8:\"\u0000*\u0000epage\";s:3:\"224\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"THOMPSON\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"GOODMAN, Phyllis J\";i:1;s:15:\"CARLIN, Susie M\";i:2;s:10:\"RYAN, Anne\";i:3;s:20:\"SZCZEPANEK, Connie M\";i:4;s:15:\"CROWLEY, John J\";i:5;s:18:\"COLTMAN, Charles A\";i:6;s:19:\"TANGEN, Catherine M\";i:7;s:15:\"LUCIA, M. Scott\";i:8;s:14:\"MILLER, Gary J\";i:9;s:14:\"FORD, Leslie G\";i:10;s:17:\"LIEBER, Michael M\";i:11;s:18:\"CESPEDES, R. Duane\";i:12;s:15:\"ATKINS, James N\";i:13;s:16:\"LIPPMAN, Scott M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"The influence of finasteride on the development of prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
